Navigation Links
The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
Date:9/13/2007

U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2006, Boehringer Ingelheim posted net sales of US $13.3 billion (10.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development. For more information, please visit http://us.boehringer-ingelheim.com.

References

1. Lancet ref

2. Lotke PA, Lonner JH. Deep venous thrombosis prophylaxis: better living

through chemistry-in opposition. J Arthroplasty 2005;20:15-7

3. Geerts WH, Pineo GF, Heit JA et al. Prevention of Venous

Thromboembolism: The Seventh ACCP Conference on Antithrombotic and

Thrombolytic Therapy. Chest 2004;126:338-400


'/>"/>
SOURCE Boehringer Ingelheim
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. Data Published in The Lancet Show Gardasil was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
3. The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
4. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
5. Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from Human Clinical Trials for New Cancer Drug
6. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
7. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
8. Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
9. Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
10. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
11. Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on Targeted, Systemic Delivery of siRNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015   Cochlear Limited (ASX: ... announced today the US Food and Drug Administration ... with Slim Straight Electrode (CI522). Built on over ... collaboration with the world,s leading surgeons, the Profile ... to provide the most discreet appearance for both ...
(Date:7/1/2015)... 2015  goBalto, Inc., the leading provider of ... growth in serving pharmaceutical, biotech and CRO companies. ... clinical trials and restrain costs, but inefficiencies tied ... stalled these efforts," said Sujay Jadhav , ... has encouraged Industry leaders, to embrace cloud-based solutions. ...
(Date:7/1/2015)... Ariz. , July 1, 2015 Prismic ... drugs and FDA-regulated medical foods, today announced the election ... A. Simonetti to its Board of Directors. ... Board members, Peter Moriarty , Chairman and CEO ... Krivulka and Martin Simonetti have accepted ...
Breaking Medicine Technology:Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 3goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2
... announces that a new market research report is ... A Preventive Vaccines - Pipeline Assessment and Market ... Hepatitis A Preventive Vaccines - ... SummaryGlobalData, the industry analysis specialist, has ...
... March 14, 2011 Reportlinker.com announces that a ... catalogue: Insulin Lispro - Comprehensive ... Eliminate unnecessary risk with the industry ... Developer is a regularly updated, professional patent search ...
Cached Medicine Technology:Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Insulin Lispro - Comprehensive Patent Search 2Reportlinker Adds Insulin Lispro - Comprehensive Patent Search 3Reportlinker Adds Insulin Lispro - Comprehensive Patent Search 4
(Date:7/2/2015)... Somerset, N.J. (PRWEB) , ... July 02, 2015 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... Eberbach, Germany, facilities. , Dr. Irmgard Neuper is the new General Manager at ...
(Date:7/2/2015)... ... ... can have an effect on the body. And during the hot summer season, fitness guru ... eating enough of the right foods, as well as drinking plenty of water. , But ... the food front as well, with sweet treats like ice cream and snow cones more popular ...
(Date:7/2/2015)... ... July 02, 2015 , ... Denver-based SlimGenics Weight Control ... was named No. 14 on ColoradoBiz magazine’s Top 100 Woman-Owned Companies list. ColoradoBiz ... been recognized. The award identifies outstanding woman-owned businesses that demonstrate excellence and success ...
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. Jian-Dong Li, a ... and a Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received ... infections. , The grant from the National Institute on Deafness and Other Communication ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... that they will welcome four new members to their industry leading Scientific Advisory ...
Breaking Medicine News(10 mins):Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5
... Chairman, Tony Strange Appointed to CEO position and Will Join ... , MELVILLE, N.Y., Nov. 18 /PRNewswire-FirstCall/ -- ... a leading provider of comprehensive home health services, announced today ... plan. Effective January 1, 2009, Tony Strange will become ...
... by contact with blood, respiratory secretion , , TUESDAY, Nov. ... of a tick-borne disease called granulocytic anaplasmosis (HGA), which ... described in a study by researchers at China,s National ... the first known report of human-to-human transmission of HGA. ...
... of Michigan is,asking Attorney General Mike Cox to stand ... that are,included in a compromise on health insurance reform ... conference committee of the Michigan House and,Senate. , ... has a vested interest in ensuring that all,Michigan consumers ...
... allergic reactions, other problems have surfaced with these products, ... American women who turn to cosmetic treatments called dermal ... to the health risks these products pose, an advisory ... Tuesday. , The panel of independent experts urged the ...
... SEATTLE, Nov. 18 Just in time ... new Web site http://www.ShopForCancerCures.org to,benefit ... Center,( http://www.fhcrc.org ) and 10 other world-class ... ( http://www.cancerresearchalliance.org ). A portion of,each purchase ...
... ability to live and function when enrolled in tailored interventions ... get elderly cancer survivors to eat better and exercise more ... a new study says. , The Texas study found ... ability, lost weight and body mass when enrolled in a ...
Cached Medicine News:Health News:Gentiva Health Services Confirms Management Succession 2Health News:Gentiva Health Services Confirms Management Succession 3Health News:Gentiva Health Services Confirms Management Succession 4Health News:China Documents First Case of Tick-Borne Disease Spread 2Health News:Blue Cross Blue Shield of Michigan Calls for Attorney General to Support Stronger Regulation of Commercial Insurers; Protections for Consumers; and Financially Stable Insurance Market 2Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 2Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 3Health News:Fred Hutchinson Cancer Research Center Benefits From Shopping Site 2Health News:Fred Hutchinson Cancer Research Center Benefits From Shopping Site 3Health News:Home-Based Programs Benefit Older Cancer Survivors 2
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
... product line has the right product for ... and from intubated patients to patients with ... both anesthesia and critical care applications., ... protection for patients and staff members. This ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Ballard trach care HMES and filters, universal use, "Y" filter, CO 2 sampling port...
Medicine Products: